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Although von Hippel–Lindau protein (pVHL) is known as a tumor suppressor in kidney and other
organs, it remains unclear whether pVHL plays a role in lung cancer development. We investigated
the role of pVHL in lung cancer cell proliferation, migration, and colonization using stable A549 cells
with knockdown of pVHL. We found that knockdown of pVHL promotes epithelial-mesenchymal
transition (EMT) in lung cancer cells. Knockdown of pVHL decreased tumor colonization in a tail-
vein injection model and decreased cell proliferation, whereas overexpression of constitutive active
HIF increased tumor colonization, suggesting a HIF-independent function of pVHL in lung. Knock-
down of pVHL decreased phosphorylation of FAK and expression of integrin, suggesting that pVHL
regulates lung cancer development via integrin/FAK signaling pathway.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Lung cancer is the most common cause of cancer-related death
in the United States [1]. There are two main types of lung cancer,
small cell lung cancer and non-small cell lung cancer (NSCLC) [1],
which accounts for 80% of lung cancer cases. Patients with meta-
static cancer have poorer survival rates [2–6]. Tumor metastasis in-
cludes many steps: loss of cellular adhesion, increased motility and
invasiveness, entry and survival in the circulation, exit into new
tissue and colonization at a distant site [7]. The rate-limiting step
is the acquisition of motility and invasive ability, which are charac-
teristics of cells that have undergone epithelial-mesenchymal tran-
sition (EMT) [5,8]. EMT is a molecular and cellular process, during
which epithelial cells lose epithelial markers such as E-cadherin
and gain mesenchymal markers such as a smooth muscle actin
(a-SMA) and vimentin [9–11]. The signiﬁcance of EMT in tumor
metastasis has recently been reported in a few tumor models
[12,13].chemical Societies. Published by E
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60612, USA. Fax: +1 312 996Von Hippel–Lindau protein (pVHL) was ﬁrst identiﬁed as a tu-
mor suppressor because the mutation of pVHL gene is associated
with tumors in kidney [14,15]. The most studied function of pVHL
is acting as a component of ubiquitin protein ligase (E3) for the
proteasomal degradation of hypoxia inducible factor (HIF)-1/2a
[16–18]. In renal carcinoma and other cancers, mutation of pVHL
leads to stabilization of HIF, which drives angiogenesis and cancer
development. Although lungs express levels of pVHL comparable
to kidneys [19,20] and loss of VHL allele frequently occurs in pa-
tients with non-small cell lung cancer [21–23], it remains unclear
whether pVHL plays a role in lung cancer development.
We investigated the role of pVHL in the proliferation, migration,
and colonization of lung cancer cells. Our results suggest that
although knockdown of pVHL in lung cancer cells induces EMT
phenotypes in vitro, it decreases lung cancer cell colonization in
lungs of nude mice, possibly through decreased cell proliferation
in a HIF-independent but integrin/FAK signaling dependent
manner.
2. Materials and methods
2.1. Cell culture
A549 (Human lung adenocarcinoma cells) were purchased from
the American Type Tissue Collection and grown in DMEM supple-
mented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, and
100 lg/ml streptomycin. Cells were incubated in a humidiﬁedlsevier B.V. All rights reserved.
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cell line with suppression of pVHL by small hairpin RNAs (shRNAs),
as previously described [24]. Since A549 cells expressing shRNA of
Drosophila melanogaster HIF (A549-sh-dHIF)were used as control
and dHIF shRNA construct does not target human HIF and has no
effect on endogenous HIF [24]. These cell lines were maintained
in media containing 1 lg/ml puromycin (Sigma–Aldrich, St. Louis,
MO). A549-Lxin (retroviral vector infected cells) and A549-HIF-
DPA (express constitutive active HIF-1a) were described previ-
ously [25] and were maintained in media containing geneticin
G418 (400 lg/ml; Invitrogen, Carlsbad, CA). Cell cultures were
routinely passaged when they are 85–90% conﬂuent. Cell numbers
were counted with Bio-Rad TC10 automated cell counter (Bio-Rad,
Hercules, CA).
2.2. Western blotting
Cells were washed three times with ice-cold phosphate-buf-
fered saline (PBS) and lysed in mRIPA buffer (50 mM Tris pH
7.4, 1% NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, and prote-
ase inhibitors). The cell lysates were cleared by centrifugation
at 13,000g for 5 min and protein concentrations of the superna-
tants were determined using a DC protein assay (Bio-Rad, Hercu-
les, CA). Typically, 25–50 lg of protein were then separated by
SDS–polyacrylamide gel electrophoresis. The gel was transferred
using a Semi-Dry transfer cell (Bio-Rad) to BA-S 85 nitrocellulose
membrane (OPTITRAN, Middlesex, UK). Proteins were detected
with SuperSignal West Pico Chemiluminescent Substrate (Ther-
moScientiﬁc, Rockford, IL). The following antibodies were used
in this study: a-tubulin, actin, vimentin (Sigma–Aldrich, St. Louis,
MO), a-smooth muscle actin (a-SMA) (R&D Systems, Minneapo-
lis, MN), E-cadherin (Santa Cruz Biotechnology Inc., Santa Cruz,
CA), Focal adhesion kinase (FAK) and pFAK (Invitrogen, Carlsbad,
CA), integrin a4 (Chemicon,Temecula, CA), integrin b1 (Santa Cruz
Biotechnology, Santa Cruz, CA), HIF-2a (Novus Biologicals,
Littleton, CO), HIF-1a (BD transduction Laboratories, Franklin
Lakes, NJ).2.3. Scratch assay
Cells were cultured at the density of 0.8 million cells per 35 mm
dish and incubated overnight. Wounds were created by scratching
a straight line with a 250 ll tip vertically in the center of the dish.
Dishes were washed with complete media once to remove de-
tached cells and the ﬁrst image of the wound was taken under
microscope. The width of the wounds was measured with AxioVi-
sion LE software (Zeiss, Oberkochen, Germany). Dishes were then
put back in an incubator and incubated for 24 ho and the width
of the wounds was measured as described above. The difference
between the widths is taken as the migration distance.2.4. Cell invasion assay
Cell invasion assay was performed with BD Matrigel invasion
chambers (BD BioCoat, Bedford, MA, USA). Brieﬂy, after transwells
and inserts were warmed up, 0.5 ml cell suspension (5  104/ml)
and 0.75 ml media were added into inserts and wells, respectively.
Cells were allowed to attach for 4 h and were cultured for 2 days.
Uninvaded cells in the upper chamber were removed with cotton
swabs and invaded cells were ﬁxed with 100% methanol for
2 min and stained with 0.5% crystal violet in 2% methanol for
2 min. For each insert, at least ﬁve random microscopic ﬁelds
(200 magniﬁcation) were counted. Experiments were carried
out in triplicates.2.5. Tail vein assay of lung cancer cell colonization
Cells were dissociated into a single cell suspension and the den-
sity of cell suspension was adjusted with PBS to 107 cells/ml. Athy-
mic mice were purchased from Harlan Laboratories (Indianapolis,
Indiana) and were maintained on a 12h:12 h light–dark cycle in
the Biologic Resources Laboratory. All experimental protocols were
approved by the Institutional Animal Care and Use Committee of
the University of Illinois at Chicago following National Institutes
of Health guidelines. Mice were placed in a mouse tail illuminator
(Braintree Scientiﬁc Inc., Braintree, MA) with the tail protruding
through the opening in the wall of the restraining device. One mil-
liliter syringe was ﬁlled with the cell suspension and 0.2 ml of the
cell suspension was slowly injected into the lateral tail vein of
nude mice with a 27G1/2 needle. After 5 weeks, the animals were
euthanized and their lungs were removed. Left lungs were rinsed
in PBS and placed in a beaker containing Bouin’s solution (0.9%
(v/v) picric acid, 9% (v/v) formaldehyde, 5% (v/v) acetic acid) over-
night. After removing the excess Bouin’s solution by rinsing the
lungs with PBS, the numbers of pulmonary tumor colonies were
counted with the aid of a dissecting microscope. Right lungs were
ﬁxed in 10% formaldehyde and processed for H&E staining and rep-
resentative microscopic images were obtained with AxioVision LE
software.
2.6. Statistical analysis
Statistical analysis was done using GraphPad Prism 4 (Graph-
Pad, San Diego, CA, USA) and Microsoft Excel (Microsoft, Redmond,
WA, USA) when applicable; t tests were performed and signiﬁcant
difference values were set at 0.05.
3. Results
3.1. Knockdown of pVHL promotes epithelial-mesenchymal transition
(EMT) and migration in lung cancer cells
To determine whether loss of pVHL affects lung cancer cell phe-
notypes, we established an A549 cell line with suppression of pVHL
by shRNA as described previously [24]. As shown in Fig. 1A that
pVHL expression was suppressed in the A549-sh-VHL cells. Since
A549 cells express both HIF-1a and HIF-2a and loss of pVHL stabi-
lizes HIF-a [24], we determined the expression of HIF-1a and HIF-
2a in A549-sh-VHL cells. As shown in Fig. 1B, knockdown of pVHL
stabilized both HIF-1a and HIF-2a. Previous studies reported that
in renal carcinoma cells loss of pVHL decreased expression of E-
cadherin, which is associated with EMT [10,26–28]. Thus we inves-
tigated whether loss of pVHL in A549 cells alters expression of EMT
markers. As shown in Fig. 1B, knockdown of pVHL increased
expression of a-SMA and vimentin and decreased expression levels
of E-cadherin. Since EMT is known to increase cell motility [9–11],
we performed scratch assay to determine cell motility in these
cells and as shown in Fig. 1C and D, knockdown of pVHL increased
A549 cell migration. In addition, A549-sh-VHL cells were more
invasive than control cells (Fig. 1E).
3.2. Knockdown of pVHL decreases A549 cell proliferation and
colonization in lung
We compared the cell proliferation rates of A549, A549-sh-dHIF
and A549-sh-VHL and as shown in Fig. 2A, cells with suppression
of pVHL proliferated at a slower rate than control cells. To investi-
gate the consequence of loss of pVHL in the colonization of A549
cells, we injected these cells into the lateral tail vain of athymic
nude mice and ﬁve weeks later we determined the numbers of
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Fig. 1. Knockdown of pVHL promotes lung cancer cells epithelia-mesenchymal transition (EMT) and migration. Cultured A549, A549-sh-VHL (sh-VHL), and A549-sh-dHIF
(sh-dHIF) were lysed and aliquots containing the same amount of proteins were subjected to SDS–PAGE, followed by Western blot analysis for the detection of pVHL (A), HIF-
1a, HIF-2a, E-cadherin, a-smooth muscle actin (a-SMA), and vimentin (B). Actin (A) and Tubulin (B) were used as control for equal loading. (C) Cells were cultured on 35 mm
dishes overnight to reach conﬂuence. Wounds were created by scratching a straight line with a 250 rmul tip and the images of original wound were taken and the starting
width were measured with AxioVision LE software (Zeiss). After 24 h incubation, the width of the wounds was measured as described above and the difference between the
width before and after migration was presented as the migration distance. Representative images of the width of the wounds before and after migration were shown and the
quantitation of the migration distances was shown in (D). Data were expressed as mean ± S.E.M. n = 5. ⁄⁄P < 0.01. (E) Cells were cultured on BDMatrigel invasion chambers for
48 h. Invaded cells were stained and the number of invaded cells in each ﬁeld was counted under microscopic ﬁelds at 200magniﬁcation. Experiments were carried out in
triplicates and repeated three times. The results were compared to that of A549 cells and data are expressed as mean + S.E.M. ⁄⁄P < 0.01.
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C, knockdown of pVHL decreased the number of the tumor nod-
ules, suggesting that knockdown of pVHL in lung cancer cells
inhibits lung cancer cell colonization.
3.3. Overexpression of the constitutive active HIF increases lung cancer
cell colonization
Since the loss of pVHL is associated with activation of HIF
(Fig. 1B) [29,30], we then determined whether the loss-of-function
of pVHL in A549 cells is due to the gain-of-function of HIF. We
established a cell line with constitutive expression of nondegrad-
able HIF-1a [25] and determined their proliferation rates and
the colonization potential in the tail vein assay. As shown in
Fig. 3, overexpression of the constitutive active HIF-1a did notsigniﬁcantly alter cell proliferation in lung cancer cells, whereas
increased the number of tumor nodules in nude mice, suggesting
that overexpression of constitutive active HIF increases lung can-
cer cell colonization.
3.4. Knockdown of pVHL decreases integrin/focal adhesion kinase
(FAK) signaling
Our results showed that loss of pVHL prevented lung cell colo-
nization (Fig. 2) whereas constitutive HIF promotes lung cancer
colonization (Fig. 3), thus we reason that the HIF-independent
function of pVHL overrides the HIF-dependent function during
lung cancer cell colonization in pVHL null lung cancer cells. Previ-
ously we have shown that overexpression of pVHL promotes ﬁbro-
blast proliferation via intergrin/FAK signaling independent of HIF
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Fig. 2. Knockdown of pVHL decreases A549 cell proliferation and colonization. (A)
Cells were cultured in dishes with starting number of 2  105/dish. 1, 3, 5, and 7
days after incubation, the total numbers of cells in each dish were counted. The
experiments were carried out in triplicates and repeated three times. Data were
expressed as mean ± S.E.M. n = 3. ⁄⁄P < 0.01. (B) Two million cells were injected into
athymic nude mice via the lateral tail vein. After ﬁve weeks, lungs of these mice
were removed and stained with Bouin’s solution and the tumor nodules on the left
lungs were counted under a dissecting microscope. Data were expressed as
mean ± S.E.M. n = 8. ⁄⁄P < 0.01. Representative microscopic images of the H&E
staining of the right lungs of these mice were shown in (C). Arrows indicate the
location of the tumor nodules.
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Fig. 3. Overexpression of constitutive HIF increases lung cancer cell colonization.
(A) Cells were cultured in dishes with starting number of 2  105/dish. 1, 3, 5, and 7
days after incubation, the total numbers of cells in each dish were counted. The
experiments were carried out in triplicates and repeated three times. Data were
expressed as mean ± S.E.M. n = 3. (B) Two million cells were injected into athymic
nude mice via the lateral tail vein. After ﬁve weeks, lungs of these mice were
removed and stained with Bouin’s solution and the tumor nodules on the left lungs
were counted under a dissecting microscope. Data were expressed as mean ± S.E.M.
n = 8. ⁄P < 0.05. Representative microscopic images of the H&E staining of the right
lungs of these mice were shown in (C). Arrows indicate the location of the tumor
nodules.
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grin and FAK phosphorylation. As shown in Fig. 4, knockdown of
pVHL decreased expression levels of integrin a4 and integrin b1.
Accordingly, the phosphorylation of FAK, a downstream signaling
molecule of integrin pathway was reduced (Fig. 4C).
4. Discussion
Although it is well established that pVHL acts as a tumor sup-
pressor in many organs especially in kidney [32], the role of pVHL
in lung cancer development is largely unknown. In our study, we
provide evidence that although lung cancer cells with knockdown
of pVHL appear to acquire the EMT phenotype, such as increased
migration, invasion, and elevated expression of a-SMA and vimen-
tin, loss of pVHL inhibits lung cancer cell proliferation and coloni-
zation in a HIF-independent manner.
Our results that knockdown of pVHL results in the EMT pheno-
type (Fig. 1) are in line with previous reports that knockdown of
pVHL decreases the expression of tight junction components,
including occludin and claudin 1 [33] and that in renal carcinoma
cell knockdown of pVHL results in the loss of E-cadherin expres-
sion and EMT [26–28]. Together, these data suggest that pVHL
participates in the maintenance of epithelial cell junction and
epithelial phenotype in lung. Cells undergoing EMT gain increased
motility and indeed we have shown that knockdown of pVHL
increases lung cancer cell motility and invasiveness (Fig. 1).Similarly, a previous report shows that overexpression of pVHL
inhibits cell motility via formation of focal adhesion and decreased
stabilizing of actin organization [34].
In renal carcinoma cells, loss of pVHL promotes EMT, resulting
in elevated invasion and cancer progression [26–28]. However,
our study suggests that knockdown of pVHL also promotes EMT
but prevents lung cancer proliferation and cell colonization
(Fig. 2), suggesting that the role of pVHL in cancer development
may vary in different tissue types. Indeed, loss of pVHL also re-
duces cell proliferation in ﬁbroblasts, mammary epithelial cells,
and chondrocytes [35–37]. Interestingly, cells with HIF-DPA have
increased lung cancer cell colonization (Fig. 3) and dominant
negative HIF inhibits lung cancer colonization [38]. These results
suggest a HIF-independent function of pVHL in lung cancer
progression.
To understand the mechanism underlining the HIF-independent
function of pVHL in our model, we have investigated the effects of
knockdown of pVHL on integrin/FAK signaling pathway, which is
critical for cell proliferation and cancer development and has been
implicated in pVHL-mediated ﬁbroblast proliferation and extracel-
lular matrix assembly [31,39–42]. We have found that knockdown
of pVHL decreases expression levels of integrin a4 and b1 and de-
creases FAK phosphorylation in A549 lung cancer cells (Fig. 4). Our
results are in line with previous studies that FAK is overexpressed
in lung cancer cells and inhibition of FAK prevents lung cancer cell
proliferation and lung cancer progression [43–45]. Consistently,
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Fig. 4. Knockdown of pVHL decreases expression of integrin a4b1 and downreg-
ulates FAK phosphorylation. Cultured A549-sh-VHL, and A549-sh-dHIF were lysed
and aliquots containing the same amount of proteins were subjected to SDS–PAGE,
followed by Western blot analysis for the detection of integrin a4 (A), integrin b1
(B), total FAK and phosphorylated FAK (C). Tubulin was used as control for equal
loading.
1514 Q. Zhou et al. / FEBS Letters 586 (2012) 1510–1515Zhao et al. reported that inhibition of integrin a4 reduces lung col-
onization of melanoma cells [46]. However, in other studies activa-
tion of FAK is associated with increased migration [47,48]. It is
worth to point out that activation of FAK by integrin aVb3 induces
migration [47], whereas we showed that loss of integrin a4b1/FAK
correlated with elevated migration and invasion, suggesting that
the function of FAK on cell migration, invasion, and colonization
may depend on the type of integrin that activates it.
Taken together, we provide evidence that HIF-independent
function of pVHL overrides HIF-dependent function to regulate
lung cancer progression, similar to that in mammary epithelium
[36]. It also suggests that pVHL suppression alone may not be suf-
ﬁcient to induce cancer in some tissues such as lung or mammary
gland [36], mostly because in these tissues loss of pVHL induces
cell growth arrest and decreases the proliferation of cells [35–
37]. However, non-small cell lung cancer patients frequently con-
tains loss of VHL allele [21–23] and loss of VHL allele increases lung
cancer susceptibility [49], we speculate that it is in conjunction
with the mutation of other tumor suppressor genes that pVHL
deletion/mutation may contribute to lung cancer progression and
further studies are warranted.
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